C56H87NO16
1030.3 g/mol
APIDanger
Temsirolimus
CAS162635-04-3
Category
API
Compound Class
Natural Product
Primary Use
Pharmaceutical Raw Material
Temsirolimus is an active pharmaceutical ingredient and a derivative of sirolimus. It is a prodrug used as a compound in pharmaceutical manufacturing for certain oncology applications.
pharmaceutical raw material for renal cell carcinoma therapyprodrug for mammalian target of rapamycin (mTOR) inhibition research
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Temsirolimus?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Related Compounds
SimilarStructure SimilarSimilarity 0.85
Everolimus
CAS159351-69-6
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.84
Sirolimus
CAS53123-88-9
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.84
Sirolimus Impurity 2
CAS157182-37-1
Pharmaceutical impurity reference standard
ReferenceSame Category
Zorifertinib
CAS1626387-80-1
pharmaceutical raw material
ReferenceSame Category
Azd-8186
CAS1627494-13-6
pharmaceutical raw material
ReferenceSame Category
[2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]methanone
CAS1627902-21-9
pharmaceutical raw material
ReferenceSame Category
Caspofungin
CAS162808-62-0
pharmaceutical raw material
Safety Reference
Danger
H360May damage fertility or the unborn child
H410Very toxic to aquatic life with long lasting effects
Customs Tariff Classification
The international HS code for Temsirolimus (CAS 162635-04-3) is 2934.99.
HS code (international, 6-digit)
2934.99
EU CN code (8-digit)
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
Identifiers
IUPAC Name
[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
InChIKey
CBPNZQVSJQDFBE-FUXHJELOSA-N
SMILES
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC
Synonyms (18)
- AB01274736-01
- Cci 779
- SDCCGSBI-0654330.P001
- TEMSIROLIMUS [MART.]
- Temserolimus
- Temsirolimus
- Temsirolimus (>80%)
- Temsirolimus Injection
- Temsirolimus, >=98% (HPLC)
- Torisel
- WAY-CCI 779
- temsirolimusum
Sourcing Temsirolimus?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.